Related Experiment Video
Updated: Jul 13, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
Central venous catheter-associated fungemia due to Rhodotorula spp. --a systematic review
Felipe F Tuon1, Gisele M Duboc de Almeida, Silvia F Costa
1Department of Infectious and Parasitic Diseases, School Of Medicine, University of Sao Paulo, Cerqueira, Sao Paulo, Brazil. ffbt@pop.com.br
Abstract:
Rhodotorula spp. are emergent opportunistic pathogens, particularly in immunocompromised individuals. They have been associated with endocarditis, peritonitis, meningitis endophthalmitis and catheter-associated fungemia. The aim of this study was to review all cases of central venous catheter-related fungemia due to Rhodotorula spp. reported in the literature in order to determine the best management of this uncommon infection. All patients but one in the 88 cases examined had some form of underlying disease including sixty-nine (78.4%) who had cancer. Rhodotorula mucilaginosa was the species most frequently recovered (75%), followed by Rhodotorula glutinis (6%). Amphotericin B deoxycholate was the most common antifungal agent used as treatment and the overall mortality was 9.1% in this review. This fungemia is a rare disease which can be found in immunocompromised and in the intensive care patients. The use of specific antifungal therapy may be associated with an increase in the survival. It should be noted that Rhodotorula spp. is resistant to fluconazole.
Insights
Rhodotorula fungemia, a rare infection in immunocompromised patients, is often linked to central venous catheters. Amphotericin B deoxycholate showed effectiveness, while fluconazole resistance was noted.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Background:
- Rhodotorula spp. are opportunistic pathogens causing severe infections like fungemia, especially in immunocompromised individuals.
- Central venous catheter-related fungemia by Rhodotorula spp. is an uncommon but serious complication.
Purpose of the Study:
- To review literature cases of Rhodotorula spp. central venous catheter-related fungemia.
- To determine optimal management strategies for this rare infection.
Main Methods:
- Systematic literature review of reported cases of Rhodotorula spp. fungemia.
- Analysis of patient demographics, underlying conditions, causative species, treatments, and outcomes.
Main Results:
- Eighty-eight cases were reviewed, with most patients having underlying conditions, predominantly cancer (78.4%).
- Rhodotorula mucilaginosa (75%) was the most frequent species. Amphotericin B deoxycholate was the primary treatment, associated with a 9.1% overall mortality.
- Rhodotorula spp. demonstrated resistance to fluconazole.
Conclusions:
- Rhodotorula spp. fungemia is a rare but significant infection, particularly in intensive care and immunocompromised patients.
- Specific antifungal therapy, such as Amphotericin B deoxycholate, may improve survival rates.
- Fluconazole is ineffective against Rhodotorula spp. due to inherent resistance.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis
Fungal Group Zygomycota
Antifungal Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

